Xr Securities LLC Biogen Inc. Call Options Transaction History

Xr Securities LLC

$5.35 Billion
Q4 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 08, 2024	SELL	$212.02 - $267.71 $742,070 - $936,984	-3,500 Reduced 70.0%	1,500 $323,000
Q4 2023 Feb 02, 2024	SELL	$222.59 - $267.94 $445,180 - $535,880	-2,000 Reduced 28.57%	5,000 $1.29 Million
Q3 2023 Oct 26, 2023	SELL	$253.3 - $285.89 $50,660 - $57,178	-200 Reduced 2.78%	7,000 $1.8 Million
Q2 2023 Aug 08, 2023	BUY	$275.25 - $318.06 $137,625 - $159,030	500 Added 7.46%	7,200 $2.05 Million
Q1 2023 May 02, 2023	SELL	$256.56 - $292.34 $179,592 - $204,637	-700 Reduced 9.46%	6,700 $1.86 Million
Q4 2022 Jan 03, 2023	SELL	$252.44 - $306.72 $1.72 Million - $2.09 Million	-6,800 Reduced 47.89%	7,400 $238,000
Q3 2022 Oct 18, 2022	BUY	$194.69 - $268.46 $2.76 Million - $3.81 Million	14,200 New	14,200 $467,000
Q3 2021 Oct 14, 2021	SELL	$282.99 - $369.05 $1.81 Million - $2.36 Million	-6,400 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $1.86 Million - $2.99 Million	-7,200 Reduced 52.94%	6,400 $272,000
Q4 2020 Jan 13, 2021	BUY	$236.26 - $355.63 $3.21 Million - $4.84 Million	13,600 New	13,600 $77,000
Q1 2020 Apr 09, 2020	SELL	$268.85 - $341.04 $2.82 Million - $3.58 Million	-10,500 Closed	0 $0
Q4 2019 Jan 06, 2020	SELL	$220.06 - $304.07 $132,036 - $182,442	-600 Reduced 5.41%	10,500 $290,000
Q1 2019 Apr 08, 2019	SELL	$216.71 - $338.96 $303,394 - $474,544	-1,400 Reduced 11.2%	11,100 $1,000
Q4 2018 Jan 03, 2019	BUY	$278.5 - $352.75 $1.73 Million - $2.19 Million	6,200 Added 98.41%	12,500 $56,000
Q3 2018 Oct 04, 2018	BUY	$293.51 - $383.83 $1.85 Million - $2.42 Million	6,300 New	6,300 $228,000

Others Institutions Holding BIIB

# of Institutions

992

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.

Account